2019 Safety Technology 
Online Laser Training
DECEMBER 8, 2019
Dr Godfrey Town gave a talk on ‘ Update on Home-Use Devices: New Devices, Regulations & Safety ’ as an Invited Speaker at the new European Congress on Advanced Treatments and Technologies in Skin & Aesthetics (Skin-Med2019) annual conference held 5th to 8th December 2019 at the Holton Munich City Hotel in Germany.
Online Laser Training
DECEMBER 8, 2019
Dr Godfrey Town gave a talk on ‘ Update on Home-Use Devices: New Devices, Regulations & Safety ’ as an Invited Speaker at the new European Congress on Advanced Treatments and Technologies in Skin & Aesthetics (Skin-Med2019) annual conference held 5th to 8th December 2019 at the Holton Munich City Hotel in Germany.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Online Laser Training
DECEMBER 8, 2019
Dr Godfrey Town gave a talk on ‘ Update on Home-Use Devices: New Devices, Regulations & Safety ’ as an Invited Speaker at the new European Congress on Advanced Treatments and Technologies in Skin & Aesthetics (Skin-Med2019) annual conference held 5th to 8th December 2019 at the Holton Munich City Hotel in Germany.
Aesthetics Advisor
MARCH 10, 2024
Americans are increasingly taking control of their health via the use of health monitoring technologies, with notable benefits as a result. A Cleveland Clinic survey revealed that 50% of Americans use at least one type of technology to track their health, with most experiencing significant related physical and mental improvements.
The Dermatology Digest
NOVEMBER 12, 2024
Vic Narurkar, MD, Innovations in Aesthetic Dermatology Lecture This special lecture was instituted in 2019 to honor Dr. Narurkar’s legacy and extraordinary contributions in the field of aesthetic dermatology. Matarasso, MD, presented the 2024 lectureship.
The Dermatology Digest
AUGUST 13, 2024
Nemolizumab was granted Breakthrough Therapy Designation in December 2019 and Priority Review in February 2024 by the U.S. The phase III OLYMPIA 1 and OLYMPIA 2 clinical trials evaluated the efficacy and safety of nemolizumab administered subcutaneously every four weeks in more than 500 patients with prurigo nodularis.
Aesthetics Advisor
AUGUST 18, 2023
Recent Studies It wasn’t until a 2019 pilot study , sponsored by NAD Research Inc, that bloodstream (plasma) NAD+ concentration was measured upon IV NAD+ (in normal saline) infusion. 2019 | Frontiers in Aging Neuroscience ) Plasma NAD+ Levels During IV Infusion. 2019 Sep 12;11:257. 4: Technology and Medication Safety).
Expert insights. Personalized for you.
60 
Let's personalize your content